Mission Pharmacal announced that Uribel (methenamine, sodium phosphate monobasic, phenyl salicylate, methylene blue, hyoscyamine sulfate capsules) is available for the treatment of irritative voiding; for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections; and for the relief of urinary tract symptoms caused by diagnostic procedures. Each capsule of Uribel contains methenamine 118mg, sodium phosphate monobasic 40.8mg, phenyl salicylate 36mg, methylene blue 10mg, hyoscyamine sulfate 0.12mg.

For more information call (210) 696-8400 or visit www.uribelinfo.com.